Baroreflex activation therapy reduces frequency and duration of hypertension-related hospitalizations in patients with resistant hypertension

Purpose Baroreflex activation therapy (BAT) has been shown to lower blood pressure in patients with resistant hypertension. The purpose of this study was to analyze whether this translates into a reduction of more relevant clinical endpoints. Methods Patients with resistant hypertension were treated...

Full description

Saved in:
Bibliographic Details
Published in:Clinical autonomic research 2020-12, Vol.30 (6), p.541-548
Main Authors: Halbach, Marcel, Grothaus, David, Hoffmann, Fabian, Madershahian, Navid, Kuhr, Kathrin, Reuter, Hannes
Format: Article
Language:English
Subjects:
Antihypertensives
Baroreceptors
Blood pressure
Cardiology
Diabetes
Endocrinology
Gastroenterology
Heart rate
Hospitalization
Hypertension
Medicine
Medicine & Public Health
Neurology
Ophthalmology
Patients
Reflexes
Research Article
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose Baroreflex activation therapy (BAT) has been shown to lower blood pressure in patients with resistant hypertension. The purpose of this study was to analyze whether this translates into a reduction of more relevant clinical endpoints. Methods Patients with resistant hypertension were treated with the second-generation BAT system. Records on hospitalization (dates of admission and discharge, main diagnosis) were obtained from medical insurance companies. Results Records on hospitalization were available for a period of 1 year before BAT in two patients and 2 years in 22 patients. The total number of hospitalizations per patient was 3.3 ± 3.5/year before BAT and 2.2 ± 2.7/year after BAT ( p  = 0.03). Hospitalizations related to hypertension were significantly decreased from 1.5 ± 1.6/year before BAT to 0.5 ± 0.9/year after BAT ( p  
ISSN:0959-9851
1619-1560
DOI:10.1007/s10286-020-00670-9